Login / Signup

Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer.

Makoto UenoKazuya SugimoriMasataka TaguriShinichi OhkawaSatoshi KobayashiHaruo MiwaTakashi KanekoManabu MorimotoTakeharu Yamanaka
Published in: Nutrition and cancer (2021)
An EPA-enriched oral supplement may be effective in advanced pancreatic cancer.
Keyphrases
  • phase ii study
  • open label
  • locally advanced
  • placebo controlled
  • phase iii
  • phase ii
  • rectal cancer
  • double blind
  • clinical trial
  • squamous cell carcinoma
  • radiation therapy
  • study protocol
  • combination therapy